News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Daily News After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes Todd Neale October 07, 2025
News Daily News Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients Todd Neale September 12, 2025
News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Conference News ESC 2025 Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support Todd Neale August 30, 2025
News Conference News ESC 2025 Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF Michael O'Riordan August 30, 2025
News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI L.A. McKeown June 05, 2025
News Conference News ESC Heart Failure 2025 No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI Todd Neale May 20, 2025
News Conference News ESC Heart Failure 2025 Cardiology Consults Tied to Better Outcomes in Patients With HF Todd Neale May 19, 2025
News Conference News THT 2025 AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF Todd Neale February 13, 2025
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM L.A. McKeown October 04, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? Michael O'Riordan October 02, 2024
News Conference News ESC 2024 FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients Michael O'Riordan September 01, 2024
News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Daily News FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF L.A. McKeown August 05, 2024